KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Astrana Health (ASTH) Revenue (2016 - 2025)

Astrana Health's Revenue history spans 16 years, with the latest figure at $956.0 million for Q3 2025.

  • For Q3 2025, Revenue rose 99.71% year-over-year to $956.0 million; the TTM value through Sep 2025 reached $2.9 billion, up 68.17%, while the annual FY2024 figure was $2.0 billion, 46.72% up from the prior year.
  • Revenue for Q3 2025 was $956.0 million at Astrana Health, up from $654.8 million in the prior quarter.
  • Across five years, Revenue topped out at $956.0 million in Q3 2025 and bottomed at $175.6 million in Q2 2021.
  • The 5-year median for Revenue is $348.2 million (2023), against an average of $398.4 million.
  • The largest annual shift saw Revenue grew 6.34% in 2021 before it soared 99.71% in 2025.
  • A 5-year view of Revenue shows it stood at $195.1 million in 2021, then skyrocketed by 50.8% to $294.2 million in 2022, then grew by 20.0% to $353.0 million in 2023, then soared by 88.43% to $665.2 million in 2024, then surged by 43.72% to $956.0 million in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Revenue are $956.0 million (Q3 2025), $654.8 million (Q2 2025), and $620.4 million (Q1 2025).